EU Pharma Adopts Sunshine Code; First Reports Are Due in 2016

July 15, 2013
The EU’s R&D-based pharma trade group has adopted new transparency measures requiring members to disclose payments to healthcare providers and organizations, beginning in 2016. The “sunshine” code, which takes effect Jan. 1, 2014, was adopted by the European Federation of Pharmaceutical Industries and Associations board on June 24 and released July 2.
International Pharmaceutical Regulatory Monitor